American Society of Clinical Oncology

Type: Organization
Name: American Society of Clinical Oncology
First reported 21 hours ago - Updated 21 hours ago - 1 reports

ASCO’s 50th Anniversary: Past Presidents Recall Top Issues During Their Terms

Emil J Freireich, MD, FASCOBernard Fisher, MD, FASCOPaul A. Bunn Jr., MD, FASCOIn a series of articles on the American Society of Clinical Oncology’s CancerProgress.Net website, past ASCO presidents are sharing their recollections of the major issues ... [Published The ASCO Post - 21 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Illumination to Innovation: Transforming Data Into Learning

By ASCOJuly 25, 2014, Volume 5, Issue 12Figures:Peter Yu, MD, FASCOIf change is inevitable, let us go out in front of it and lead.—ASCO President Peter Yu, MD, FASCO“Illumination” is a provocative word, evoking as it does the banishment of the darkness ... [Published The ASCO Post - 21 hours ago]
First reported Jul 24 2014 - Updated 23 hours ago - 2 reports

Why Variability in Cancer Care Recommendations Means You Should Consider Second Opinions | Cary A. Presant, M.D.

We know there is a surge of interest in using electronic health records to help you get better health care, and also to help healthcare administrators evaluate decisions and outcomes of patients. The federal government[1] will be using Big Data[2] (accumulation ... [Published DailyMe.Com - 23 hours ago]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Halbig ruling could affect exchange subsidies for 7.3 million Americans — Federal appeals court will hear employer mandate case

With help from Brett Norman, Sarah Wheaton and Paige Winfield CunninghamHALBIG: WHAT’S AT STAKE  – The federal appeals court in D.C. could issue a decision today in yet another highly watched Obamacare lawsuit, this one questioning whether insurance premium ... [Published Politico - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Six Points of Miscommunication Between Oncologists and Pathologists

By References1. Janne PA. What Are We Talking About: Next-Generation Sequencing, Sanger Sequencing, etc. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.2. Aisner D. Tissue is the Issue: The Pathologist’s Role in Facilitating ... [Published Cancernetwork.com - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 6 reports

Best of American Society of Clinical Oncology Symposium Set for Hollywood, FL

Aug. 29-30, 2014; Sponsored by , HOLLYWOOD, Fla.--( Each year, an ASCO expert panel selects abstracts from the ASCO Annual Meeting and licenses the program to oncology organizations worldwide.CME Credits are available for physicians, nurses, respiratory ... [Published EON: Enhanced Online News - Jul 16 2014]
First reported Jul 12 2014 - Updated Jul 12 2014 - 1 reports

He fights for cancer patients

SINGAPORE - Dr Iain Tan wears two rather big hats: He is both a research scientist and a medical doctor. But he sees his work as a perfect marriage between technology and medicine, and as being highly complementary. "There is so much progress in science ... [Published Asiaone - Jul 12 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

On the Front Lines for Our Children

Cross-posted from the American Cancer Society Cancer Action Network blog :When you think about organizations engaged in the War on Cancer, the United States Department of Agriculture (USDA) may not be the first that comes to mind. Yet, we are on the ... [Published Food and Nutrition Service - Jul 11 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Cancer research group wins award [South Bend Tribune, Ind. :: ]

July 11--SOUTH BEND -- The Northern Indiana Cancer Research Consortium, a community-based research organization that provides clinical trials for cancer patients, announced that it has been nationally honored by the Conquer Cancer Foundation of the American ... [Published BusinessWeek - Jul 11 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Gilead Sciences Can Hit Par By The End Of The Year

By Abba's Aces:The last time I wrote about Gilead Sciences, Inc. ( GILD ), I stated, "If the microeconomic news presented at the annual meeting brings the stock down due to technical reasons then I'll back up the truck and buy some more, but if the stock ... [Published BioPortfolio - Jul 10 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Eradicating Silos and Improving Communication in Cancer Care

It’s no secret that the U.S. cancer care delivery system is in crisis. Care is often not patient-centered, appropriate palliative care is lacking, and medical decisions often are not evidence-based. But when primary care physicians are closely involved ... [Published American Journal of Managed Care - Jul 08 2014]
First reported Jul 01 2014 - Updated Jul 02 2014 - 1 reports

An Update On The Buzz Around Oncology

By Kate Hammeke, Contributing EditorThe heightened interest in developing cancer treatments, combined with the R&D efforts put forth over the past decade, contributed to the emergence of a class of “smart bombs” first reported as one of their most hopeful ... [Published Life Science Leader - Jul 01 2014]

Quotes

...strategic action that will further enhance our long-term growth prospects," said Richard A Gonzalez, chairman and chief executive officer, AbbVie. "Last month, we raised our 2014 earnings-per-share guidance, reflecting strong underlying business performance. We continue to expect positive trends for the second half of the year, as well as additional progress from our pipeline, including the expected U S approval of our interferon-free HCV combination."
"We cannot avoid today the issue of the cost of care. . . . If we intend to achieve social justice in cancer care, we must define value in cancer care. . . . The assessment of value is a far more complex issue than simply adding up the price of drugs. We are clearly best positioned to serve as honest brokers in this discussion."
Jeffrey Bacha, president and CEO of DelMar stated, "The change to our year end is an important step in achieving our goal of obtaining a senior exchange listing for our shares."
...community regarding the rolapitant pivotal data set presented at the recent ASCO and MASCC conferences," said Lonnie Moulder, CEO of TESARO. "The rolapitant NDA remains on track for submission to the U S FDA in approximately six weeks, and pre-launch commercial activities are well underway. We are also pleased with the pace of enrollment in our Phase 3 niraparib NOVA trial for patients with ovarian cancer, and we expect the non-germline BRCA cohort to be fully enrolled at the end of this year."

More Content

All (566) | News (364) | Reports (0) | Blogs (169) | Audio/Video (0) | Fact Sheets (0) | Press Releases (32)
sort by: Date | Relevance
AbbVie Reports Second-Quarter 2014 Financial Re... [Published Scottrade - 7 hours ago]
Eli Lilly's (LLY) CEO John Lechleiter on Q2 201... [Published Seeking Alpha - 12 hours ago]
Inside ASCO 2014 [Published Cancernetwork.com - 16 hours ago]
Illumination to Innovation: Transforming Data I... [Published The ASCO Post - 21 hours ago]
ASCO’s 50th Anniversary: Past Presidents Recall... [Published The ASCO Post - 21 hours ago]
DelMar Pharmaceuticals Announces Change of Fisc... [Published FinanzNachrichten.de - 22 hours ago]
TESARO Announces Second-Quarter 2014 Operating ... [Published Fat Pitch Financials - 22 hours ago]
TESARO Announces Second-Quarter 2014 Operating ... [Published Myrtle Beach Sun News - 22 hours ago]
Why Variability in Cancer Care Recommendations ... [Published DailyMe.Com - 23 hours ago]
Why Variability in Cancer Care Recommendations ... [Published Huffington Post - Jul 24 2014]
Can Big Data cure cancer? [Published Fortune - Jul 24 2014]
Roche Bearer Share : with good half year perfor... [Published 4 Traders - Jul 24 2014]
FRONTLINE CANCER: The value of Comprehensive Ca... [Published LA Jolla Light - Jul 24 2014]
FDA Grants Breakthrough Therapy Designation to ... [Published The ASCO Post - Jul 23 2014]
Market Update (NYSE:ABBV): AbbVie to Host Secon... [Published BioSpace - Jul 23 2014]
"Father of Tamoxifen" to Join MD Anderson [Published Reuters - Jul 23 2014]
Salem visionary fights cancer with computer [Published South Lyon MI Herald - Jul 23 2014]
The American Society of Hematology Honors Geral... [Published American Society of Hematology - Jul 22 2014]
100 Hospitals and Health Systems With Great Onc... [Published Beckers Hospital Review - Jul 22 2014]
Zeltia diversifying its business pharma model t... [Published Pharma Letter - Jul 22 2014]
Amid Calls for Standardization, Oncology Medica... [Published OncLive - Jul 22 2014]
LIGAND PHARMACEUTICALS : TG Therapeutics Announ... [Published 4 Traders - Jul 22 2014]
Vaccine Combo Gains ‘Breakthrough Therapy’ Stat... [Published PT Community - Jul 22 2014]
The "Father of Tamoxifen" to Join MD Anderson [Published Newswise - Jul 21 2014]
Dr. Donnellan Joins Tennessee Oncology [Published Chattanoogan - Jul 21 2014]
HIStalk Interviews Amy Abernethy, MD, PhD, Chie... [Published HIStalk - Jul 21 2014]
ReproTech Releases Version 3.0 of Fertility Pre... [Published Prlog - Jul 21 2014]
Reporting the results of a controlled trial [Published JPMA - Jul 21 2014]
Data Show Benefits of Early Palliative Care for... [Published Oncology Times - Jul 20 2014]
Daily Checkup for July 20: Sarcomas [Published New York Daily News - Jul 20 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Best of American Society of Clinical Oncology S... [Published EON Science - Jul 16 2014]
HOLLYWOOD, Fla.--(EON: Enhanced Online News)--Best of ASCO Clinical Oncology Symposium; July 29, 2014 Hotel Deadline & Early Registration; summary provided by BiomedicalNews.org. ...
Best of American Society of Clinical Oncology S... [Published Business Wire Education News - Jul 16 2014]
HOLLYWOOD, Fla.--(BUSINESS WIRE)--Best of ASCO Clinical Oncology Symposium; July 29, 2014 Hotel Deadline & Early Registration; summary provided by BiomedicalNews.org. ...
Best of American Society of Clinical Oncology S... [Published Business Wire Health News - Jul 16 2014]
HOLLYWOOD, Fla.--(BUSINESS WIRE)--Best of ASCO Clinical Oncology Symposium; July 29, 2014 Hotel Deadline & Early Registration; summary provided by BiomedicalNews.org. ...
Best of American Society of Clinical Oncology S... [Published Business Wire Science: Science News - Jul 16 2014]
HOLLYWOOD, Fla.--(BUSINESS WIRE)--Best of ASCO Clinical Oncology Symposium; July 29, 2014 Hotel Deadline & Early Registration; summary provided by BiomedicalNews.org. ...
Nanobiotix revenues steady; investors focus on ... [Published Proactiveinvestors United Kingdom website - Jul 11 2014]
Nanobiotix (EPA:NANO), which is developing a significant advance on traditional radiotherapy, said revenues for the quarter were €48,596 – exactly the same as the comparable period last year. The majority of the income came in an upfront payment from ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
CollabRx Announces Successful Launch of CancerR... [Published GlobeNewswire: Advertising News - Jun 16 2014]
Karyopharm Updates Data for Selinexor in Solid ... [Published GlobeNewswire: Advertising News - Jun 02 2014]
Sunesis Announces Presentation of Positive Upda... [Published GlobeNewswire: Advertising News - Jun 02 2014]
Myriad myPath(TM) Melanoma Test Improves the Re... [Published GlobeNewswire: Advertising News - Jun 02 2014]
Myriad Presents Clinical Data on Myriad myRisk(... [Published GlobeNewswire: Advertising News - Jun 02 2014]
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.